Literature DB >> 16541076

A specific amyloid-beta protein assembly in the brain impairs memory.

Sylvain Lesné1, Ming Teng Koh, Linda Kotilinek, Rakez Kayed, Charles G Glabe, Austin Yang, Michela Gallagher, Karen H Ashe.   

Abstract

Memory function often declines with age, and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons. Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein (APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice (< 6 months old) have normal memory and lack neuropathology, middle-aged mice (6-14 months old) develop memory deficits without neuronal loss, and old mice (> 14 months old) form abundant neuritic plaques containing amyloid-beta (refs 3-6). We found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-beta assembly, which we term Abeta*56 (Abeta star 56). Abeta*56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that Abeta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541076     DOI: 10.1038/nature04533

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1101 in total

1.  An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies.

Authors:  Deborah A Ryan; Wade C Narrow; Howard J Federoff; William J Bowers
Journal:  J Neurosci Methods       Date:  2010-05-07       Impact factor: 2.390

2.  Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.

Authors:  Vitaly Vasilevko; Viorela Pop; Hyun Jin Kim; Tommy Saing; Charles C Glabe; Saskia Milton; Edward G Barrett; Carl W Cotman; David H Cribbs; Elizabeth Head
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

3.  Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Gaëlle Naert; Serge Rivest
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

4.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 5.  Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.

Authors:  Roberto Cappai; Kevin J Barnham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

6.  Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.

Authors:  Rosa Resende; Sueli C F Marques; Elisabete Ferreiro; Isaura Simões; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

7.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  EMBO J       Date:  2017-09-01       Impact factor: 11.598

8.  Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice.

Authors:  Merina Varghese; Wei Zhao; Jun Wang; Alice Cheng; Xianjuan Qian; Amna Chaudhry; Lap Ho; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2011-03-01       Impact factor: 1.757

9.  CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.

Authors:  B P Imbimbo; B Hutter-Paier; G Villetti; F Facchinetti; V Cenacchi; R Volta; A Lanzillotta; M Pizzi; M Windisch
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

10.  Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker.

Authors:  Luitgard Nagel-Steger; Borries Demeler; Wolfgang Meyer-Zaika; Katrin Hochdörffer; Thomas Schrader; Dieter Willbold
Journal:  Eur Biophys J       Date:  2009-02-24       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.